ストックスクリーナーアプリを入手
2.99
0.66%
-0.02
アフターアワーズ：
2.99
前日終値:
$3.01
開ける：
$3.07
24時間の取引高:
299.00K
Relative Volume:
4.85
時価総額：
$67.57M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-16.48%
1か月 パフォーマンス:
-1.97%
6か月 パフォーマンス:
-69.08%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$2.9558
$3.07
1週間の範囲:
$2.885
$3.75
52週間の値動き範囲:
$2.82
$12.65
Boundless Bio Inc Stock (BOLD) Company Profile
BOLD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| BOLD | 2.99 | 67.57M | 0 | 0 | 0 | 0.00 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Boundless Bio Inc (BOLD) 最新ニュース
Layoff Tracker: Sensei to Cut 46% of Workforce, Close Research Site - BioSpace
Science Spotlight: How extrachromosomal DNA drives cancer - BioCentury
Extrachromosomal DNA acts as joker for cancer cells - BioWorld Online
Pre-market Movers: REVB, CDIO, SMLR, DWTX... - RTTNews
Stanford Scientists Overturn Mendel’s Law With Shocking Cancer Discovery - SciTechDaily
Enhancing transcription–replication conflict targets ecDNA-positive cancers - Nature.com
Cullinan Therapeutics to Participate in Fireside Chat at Stifel 2024 Healthcare Conference - The Manila Times
Boundless Bio Prices IPO At $16/Shr - RTTNews
Boundless Bio CFO Jami Rubin steps down By Investing.com - Investing.com Australia
Boundless Bio CFO Jami Rubin Steps Down for Personal Reasons - MarketWatch
Boundless Bio CFO Jami Rubin steps down - Investing.com
Boundless Bio Announces Departure of Chief Financial Officer - The Bakersfield Californian
Ceribell begins trading with upsized IPO - BioWorld Online
Down rounds don’t aid post-IPO performance - BioCentury
Is Boundless Bio (NASDAQ:BOLD) In A Good Position To Invest In Growth? - Yahoo Finance
Varun Dhawan's niece Anjini Dhawan's debut film Binny and Family release postponed - India Today
BriaCell Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer Patients - GlobeNewswire
Limitless Labs Secures $3M Pre-Seed Funding Led by 1confirmation - iGaming.org
FDA Grants Breakthrough Status to Achondroplasia Drug By Investing.com - Investing.com Canada
Limitless Labs Secures $3M in Pre-Seed Funding Led by 1confirmation - Blockster
A New Prediction Market Raises $3M in Pre-Seed Round Led by 1confirmation - CoinDesk
'Binny And Family' pushed again; to now release on this date - NewsBytes
The War On Drugs On Beyoncé Collaboration: 'It’s Arguably The Coolest Thing I’ve Ever Done' - Dig!
Antibody-drug conjugate found effective against brain metastases in patients with HER2-positive breast cancer - Medical Xpress
Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference - ForexTV.com
Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference - GlobeNewswire Inc.
IPO class of 2024 shows value recovery despite mixed stock performance - BioWorld Online
Down -31.59% in 4 Weeks, Here's Why You Should You Buy the Dip in Boundless Bio, Inc. (BOLD) - MSN
SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024 - Morningstar
Boundless Bio resets stock option prices to retain talent - Investing.com
Boundless Bio Adjusts Stock Options to Incentivize Key Staff - TipRanks
Biotech Buzz: VIRX Cuts 23% Jobs, FDA Oks New Drug For Hypoparathyroidism, SIGA Down But Not Out - RTTNews
No sleep for the biotech bear: Restructurings abound in August - BioCentury
Zealand, Arrowhead advance obesity drugs; Bluebird narrows guidance - Yahoo Finance
Boundless Bio, Inc. (BOLD): Why Should You Buy This New Penny Stock Now? - Insider Monkey
BOLD Stock Earnings: Boundless Bio Beats EPS for Q2 2024 - MSN
Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial Results - wallstreet:online
Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter - The Bakersfield Californian
10 Best New Penny Stocks To Buy Now - Insider Monkey
A Guide To The Risks Of Investing In Boundless Bio Inc. (BOLD) - Knox Daily
Recent Insider Activity Suggests Potential Gains for Ellington Financial Inc (EFC) - Knox Daily
Deluxe Corp. [DLX] Investment Guide: What You Need to Know - Knox Daily
Integer Holdings Corp [ITGR] Investment Appeal on the Rise - Knox Daily
Informatica Inc [INFA] Insider Schweitzer John Arthur sells 64,501 Shares - Knox Daily
Global stock market crash likely to delay biotech IPOs - Yahoo Finance
Boundless Bio Inc (BOLD) 財務データ
Boundless Bio Inc (BOLD) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
3.66%
1.11%
大文字化:
|
ボリューム (24 時間):